Immunic | VTL - Current Assets


Immunic reported $39.27M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Alterity Therapeutics Limited AUD 37.91M 15.92M Dec/2025
BioMarin Pharmaceutical USD 3.95B 98.95M Dec/2025
Cipla INR 249.18B 16.3B Sep/2025
Clal Biotechnology ILS 14.69M 1.95M Dec/2023
Compugen USD 148.02M 59.1M Dec/2025
CSL USD 11.85B 1000K Dec/2025
Enanta Pharmaceuticals USD 198.68M 5.65M Dec/2025
Grifols EUR 5.96B 316.31M Dec/2025
Immunic USD 39.27M 20.57M Sep/2025
Insmed USD 1.79B 137.6M Dec/2025
Omeros USD 69.65M 26.53M Jun/2025
OraSure Technologies USD 261.91M 21.1M Dec/2025
Quidel USD 1.45B 80.6M Dec/2025
Ultragenyx Pharmaceutical USD 643.21M 76.58M Sep/2025
United Therapeutics USD 3.7B 208.5M Dec/2025
Xoma USD 110.71M 5.78M Sep/2025